Liver Function
Liver function in the context of zero-proof beverages refers to the liver's role in metabolizing ethanol and the well-documented benefits of alcohol reduction or abstinence for liver health. Zero-proof beverages directly eliminate alcohol's hepatotoxic effects and some botanical ingredients may actively support hepatic function.
The liver is the primary site of ethanol metabolism, processing approximately 90% of ingested alcohol via alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) enzymes. Chronic alcohol consumption causes a spectrum of liver pathology: fatty liver (reversible, from alcohol-induced fat accumulation), alcoholic hepatitis (inflammatory, partially reversible), fibrosis (partially reversible), and cirrhosis (largely irreversible). Even moderate drinking increases liver fat content and elevates liver enzymes (ALT, AST) in susceptible individuals.
The liver health benefits of alcohol reduction are well-documented and begin within days of abstinence: fatty liver starts to reverse after 2-4 weeks of abstinence; liver enzymes normalize within 4-8 weeks. This rapid clinical improvement provides a concrete, measurable health motivation for the Dry January and Tournée Minérale population — and validated by studies measuring liver markers before and after the campaign.
Some botanical ingredients used in zero-proof beverages have clinical evidence for hepatoprotective effects. Milk thistle (silymarin) is the best-evidenced hepatoprotective botanical, with multiple clinical trials showing liver enzyme normalization in patients with alcoholic and non-alcoholic liver disease. Dandelion root, artichoke leaf extract, and turmeric curcumin have more limited but promising evidence for liver support. Zero-proof beverages incorporating these botanicals at meaningful doses can legitimately claim liver-support positioning in consumer education contexts, though specific health claims on labels require appropriate regulatory authorization.
A consumer narrative that zero-proof brands can leverage: the UK NHS, Belgian health organizations, and German DKFZ (German Cancer Research Center) all publish materials linking even moderate alcohol consumption to liver risk. Positioning zero-proof beverages as a tool for liver health protection — without excessive medical claims — aligns with established public health messaging and makes zero-proof brands partners in a recognized health narrative rather than niche alternatives.